Slap cheek, also called slapped cheek syndrome or fifth disease, is a common viral infection caused by parvovirus B19. It gets its name from the bright red rash that appears across both cheeks, making it look like the face has been slapped. The infection is most common in children aged 5 to 9 but can affect anyone, and it typically resolves on its own within one to three weeks.
The medical name is erythema infectiosum. It’s called “fifth disease” because it was the fifth in a historical list of childhood illnesses that cause rashes. For most people it’s mild and unremarkable, but it can cause complications during pregnancy or in people with certain blood disorders.
What Causes It
Parvovirus B19 is a virus that spreads through respiratory droplets, the same way colds and flu travel. Coughing, sneezing, and close contact in places like schools and daycare centers are the main routes. It can also spread through blood, which is relevant during pregnancy because the virus can cross the placenta.
The virus is extremely common. About 50% of adults have antibodies to parvovirus B19 by age 20, and more than 70% have them by age 40, meaning most people catch it at some point. Teachers, daycare workers, and anyone who spends a lot of time around young children have the highest occupational risk. Once you’ve had the infection, you’re immune for life.
How Symptoms Progress
Slap cheek typically unfolds in stages, and many people barely notice the early phase. The first symptoms appear about a week after exposure and look like any mild cold: low-grade fever, headache, runny nose, and general tiredness. This early stage is when the virus is actually circulating in the blood at its highest levels, and it’s the most contagious period.
Several days later, the signature bright red rash appears on both cheeks. By this point, the body’s immune system has already begun clearing the virus, and the person is no longer contagious. This is the frustrating part for parents: the rash that finally signals what’s going on is actually a sign the infectious period has already passed. There’s no need to keep a child home from school once the rash appears.
A day or two after the facial rash, a second rash often develops on the trunk, arms, and legs. This one looks lacy or net-like, sometimes described as a “reticular” pattern. It can be mildly itchy. The body rash typically fades within a week or two but may come and go for longer, flaring up again with exposure to sunlight, heat, cold, or even a hot bath. These flare-ups don’t mean the infection is back. They’re just a skin reaction, and they gradually stop.
Symptoms in Adults
Adults who catch parvovirus B19 often have a different experience than children. The facial rash may be less obvious or absent entirely. Instead, joint pain and swelling tend to be the dominant symptom, particularly in the hands, wrists, and knees. This joint involvement can last for weeks and occasionally persists for months, which is sometimes mistaken for early rheumatoid arthritis. Women are more commonly affected by the joint symptoms than men.
Some adults have no symptoms at all. Others feel generally unwell with fatigue and body aches that linger after the initial infection clears. The joint pain, while uncomfortable, resolves without causing permanent damage.
When It Becomes More Serious
For most healthy children and adults, slap cheek is a nuisance, not a danger. But certain groups face real risks.
Pregnancy
Parvovirus B19 during pregnancy can be serious. The virus crosses the placenta and infects the developing baby in roughly 39% of maternal infections. In one large study published in the Journal of Clinical Microbiology, the overall rate of fetal death was 10.2% among pregnancies with confirmed parvovirus B19 infection.
The greatest risk comes from infection during the first trimester. The virus targets cells that are rapidly dividing, and between weeks 17 and 24 of pregnancy, the placenta has elevated levels of the receptor the virus uses to enter cells, while intense blood cell production is happening in the fetal liver. This makes the fetus especially vulnerable. The virus can cause severe fetal anemia, which in turn can lead to a condition called hydrops fetalis, where fluid accumulates abnormally in the baby’s tissues. In that study, hydrops occurred in about 12% of infected fetuses, and all cases followed first-trimester maternal infection. When hydrops did develop, it was fatal in about two-thirds of cases, though roughly 29% of surviving babies recovered fully with normal development at follow-up.
If you’re pregnant and think you’ve been exposed to someone with slap cheek, a blood test can determine whether you’re already immune or have a new infection. Most pregnant women (given those adult immunity rates) will already have protective antibodies.
Blood Disorders and Weakened Immune Systems
Parvovirus B19 temporarily shuts down the body’s production of red blood cells. In a healthy person, this pause is brief and goes unnoticed because red blood cells live for about 120 days. But in people with conditions like sickle cell disease, thalassemia, or other chronic anemias where red blood cells are already breaking down faster than normal, even a short production pause can trigger a sudden, dangerous drop in red blood cell counts. This is called a transient aplastic crisis and can require blood transfusions.
People with weakened immune systems, such as those undergoing chemotherapy or living with HIV, may not be able to clear the virus effectively. Instead of a short-lived infection, the virus can persist and cause prolonged, severe anemia.
How It’s Diagnosed
In children, the diagnosis is usually obvious from the rash alone. No testing is needed for a typical case in an otherwise healthy child.
When confirmation matters, such as during pregnancy or in someone with a blood disorder, a blood test checks for specific antibodies. IgM antibodies appear 10 to 14 days after infection and indicate a recent or current infection. They can remain detectable for up to five months. IgG antibodies show up about 15 days after infection and persist for life, indicating past infection and immunity. If only IgG is present with no IgM, you had the infection at some point and are now immune.
Treatment and Recovery
There is no antiviral medication for parvovirus B19, and for the vast majority of people, none is needed. Treatment is purely supportive: rest, fluids, and over-the-counter pain relief for fever or joint aches. Antihistamines can help if the rash is itchy.
Children typically feel fine by the time the rash appears and can continue normal activities. The rash itself, including the recurring flare-ups triggered by heat or sunlight, is cosmetic and harmless. Adults with joint pain may need to manage symptoms for a few weeks, but the discomfort resolves without lasting effects.
For high-risk individuals, treatment depends on the complication. Severe anemia from an aplastic crisis may require blood transfusions. Pregnant women with confirmed infection are monitored with ultrasound to watch for signs of fetal anemia or hydrops, and in some cases, the baby can receive a blood transfusion in the womb. People with immune deficiencies who can’t clear the virus on their own may be treated with antibody infusions to help their body fight the infection.
The Contagious Window
The timing of contagion is counterintuitive. A person with slap cheek is most contagious during the early cold-like phase, before anyone realizes it’s parvovirus B19. The virus is circulating in the blood at peak levels during the first few days of symptoms, roughly a week after initial exposure. Once the rash appears, the immune system has already produced antibodies, viral levels have dropped, and the person is no longer spreading the infection.
This makes outbreaks difficult to contain, especially in schools. By the time the first child develops the telltale red cheeks, the virus has likely already been circulating in the classroom for a week or more. Standard hand hygiene and covering coughs help reduce spread, but avoiding exposure entirely is impractical given the timing. Recent data from the CDC showed a significant jump in infections in 2024, with 40% of children aged 5 to 9 showing evidence of recent infection in June of that year, up from 15% in prior years.